 is a leading provider of products for the safe
collection and transport of diagnostic specimens and of instrumentation for quick, accurate analysis for a broad range of microbiology and infectious disease testing, including the growing problem of healthcare-associated infections. The segment is composed of two operating units: Preanalytical Systems, the world leader in blood collection devices, and Diagnostic Systems, the world leader in microbiology products.
Principal products and services include integrated systems for evacuated blood collection; an extensive line of safety-engineered specimen collection products and systems; plated media; automated blood culturing; molecular testing systems for sexually transmitted diseases; microorganism identification and drug susceptibility systems; and rapid manual testing products.
|
|
 |
 |
BD Diagnostics focuses on improving health outcomes for patients and economic outcomes for laboratories through solutions that
elevate quality, reduce costs and accelerate productivity of laboratory systems. Developing products that effectively integrate laboratory work processes, diagnostic testing procedures and effective information management is central to the business. In each of its businesses, BD Diagnostics seeks both to grow its core product platforms and innovate to expand its range of product solutions.
Preanalytical Systems is building on its leadership position in specimen collection and accelerating growth through continued emphasis on safety, offering safety-engineered sharps and plastic evacuated tubes. Innovation, an integral part of this effort, has led to second- and third-generation safety-engineered products offering greater protection and improved functionality. The conversion of emerging markets, including China, India and the Middle East, to evacuated tubes is also a priority.
Looking ahead, Preanalytical Systems is concentrating on emerging technologies–including molecular diagnostics and proteins–and will look to build capabilities in the areas of sample collection, stabilization and processing. The 2005 acquisition of FFE Weber establishes BD Diagnostics as an early mover in the protein separation market for both research and clinical applications.
Diagnostic Systems continues to be a leader in traditional microbiology and infectious disease. Its focus on growth media–for both the clinical and industrial market segments–is the foundation of strong customer relationships and is an entry point for instrument platforms. For example, BD BACTEC systems are a critical tool for microbiologists seeking rapid, accurate answers for patients with life-threatening bacterial infections. Looking forward, BD will integrate automated diagnostics platforms, linking BD BACTEC, BD ProbeTec ET and BD Phoenix systems through the unique BD EpiCenter system, a virtual “microbiology lab of the future.”
 |
 |
 |
 |
The BD Vacutainer Push Button Blood Collection Set is BD’s next-generation safety product in winged collection sets.
|
The BD EpiCenter Microbiology Data Management System interfaces seamlessly with existing laboratory information systems and various BD microbiology systems.
|
Applications for the BD ProbeTec ET system are expanding with U.S. FDA clearance of a diagnostic test for Legionella pneumophila and the upcoming launch of three tests for atypical pneumonia in Europe and Asia-Pacific.
|
The new BD Free Flow
Electrophoresis System is the only separation system that provides high-resolution fractionation and purification across an amazingly broad range–from peptides and proteins to cellular organelles.
|
|
|
